Melbourne researchers are helping expand options for people with high cholesterol that puts them at risk of heart attack or stroke, including world-first drugs for potentially deadly conditions.

American Heart Association Scientific Sessions 2024, Abstract 4171286 - The oral medication muvalaplin may safely lower high ...

The Kraken trial - A world first treatment for bad ... High levels of Lp(a) increase the risk of heart attack and stroke. As it is largely genetic, Lp(a) is difficult to control through diet, exercise ...

Still, the Ducks will be missing a major piece of their offensive attack. Mason McTavish is day-to-day and may ... Last time ...

A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein (a), according to late-breaking science presented today at the ...

Foligno believes in the theory that most NHL playoff teams are in the picture by American Thanksgiving. And with four more ...

The KRAKEN clinical trial included 233 adults around the world ... with no notable change in levels of high-sensitivity ...

People born with inherited high cholesterol — known as the “evil cousin” — may soon have access to new and potentially ...

Bruins head coach Jim Montgomery showed frustration about Jeremy Swayman's performance against the Blue Jackets.

This Fed-based market signal is flashing a warning for the first time in over a decade. Here’s why it matters.

Nintendo has announced a new update for its squid-shooter Splatoon 3 and it's packed with all sorts of adjustments. This ...

Gerardo “Tata” Martino, who guided Inter Miami to the best regular season record in Major League Soccer history this season, ...